Latest Breaking News On - Oncotype dx breast recurrence score program - Page 1 : comparemela.com

/PRNewswire/ Exact Sciences Corp. (Nasdaq: EXAS) today announced that Japan s Ministry of Health, Labor and Welfare (MHLW) has approved the Oncotype DX.

San diegoUnited statesKatie boyceKevin conroyMegan jonesSciences corpSciences on facebookEarly breast cancer trialist collaborative groupOncotype dx breast recurrence score programSciences on twitter exactsciencesExchange commissionGenomic health incJapan ministry of healthEpic sciencesSciences corporationExact sciences